APOLIPOPROTEIN A - ANVISA Registration 80146501304
Access comprehensive regulatory information for APOLIPOPROTEIN A in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501304 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including ROCHE DIAGNOSTICS GMBH, WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80146501304
25351182400200598
56998701000116
Company Information
Dates and Status
Nov 07, 2005
VIGENTE
09/18/2025 19:00:01
APOLIPOPROTEÍNA A
LPA2 (Tina-quant Lipoprotein (a) Gen.2)-cobas c
ROCHE DIAGNOSTICS GMBH
10287411429
Aug 05, 2019
APOLIPOPROTEÍNA A
FAMÍLIA APOLIPOPROTEIN E
WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD
80464810662
Jun 24, 2019
APOLIPOPROTEÍNA A
PreciControl Lp(a) Gen. 2
ROCHE DIAGNOSTICS GMBH
10287411033
Dec 30, 2013
APOLIPOPROTEÍNA A
Preciset Lp(a) Gen.2
ROCHE DIAGNOSTICS GMBH
10287411034
Dec 30, 2013

